These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8795476)

  • 1. Double blind placebo controlled trial of short term transdermal scopolamine on heart rate variability in patients with chronic heart failure.
    Venkatesh G; Fallen EL; Kamath MV; Connolly S; Yusuf S
    Heart; 1996 Aug; 76(2):137-43. PubMed ID: 8795476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure.
    Casadei B; Conway J; Forfar C; Sleight P
    Heart; 1996 Mar; 75(3):274-80. PubMed ID: 8800992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction.
    De Ferrari GM; Mantica M; Vanoli E; Hull SS; Schwartz PJ
    J Am Coll Cardiol; 1993 Nov; 22(5):1327-34. PubMed ID: 8227788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scopolamine improves autonomic balance in advanced congestive heart failure.
    La Rovere MT; Mortara A; Pantaleo P; Maestri R; Cobelli F; Tavazzi L
    Circulation; 1994 Aug; 90(2):838-43. PubMed ID: 8044956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose transdermal scopolamine decreases blood pressure in mild essential hypertension.
    Vesalainen RK; Kaila TJ; Kantola IM; Tahvanainen KU; Juhani Airaksinen KE; Kuusela TA; Eckberg DL
    J Hypertens; 1998 Mar; 16(3):321-9. PubMed ID: 9557925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction.
    Vybiral T; Glaeser DH; Morris G; Hess KR; Yang K; Francis M; Pratt CM
    J Am Coll Cardiol; 1993 Nov; 22(5):1320-6. PubMed ID: 8227787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of transdermal scopolamine on heart rate variability in patients with severe coronary heart disease.
    Kochiadakis GE; Rombola AT; Kanoupakis EM; Zuridakis EG; Skalidis EI; Vardas PE
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1867-71. PubMed ID: 8945058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral pirenzepine on heart rate variability and baroreceptor reflex sensitivity after acute myocardial infarction.
    Pedretti RF; Colombo E; Sarzi Braga S; Ballardini L; Carù B
    J Am Coll Cardiol; 1995 Mar; 25(4):915-21. PubMed ID: 7884097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose transdermal scopolamine increases cardiac vagal tone in patients after acute myocardial infarction.
    Wang L; Wang L; Zhang Y; Zhang B; Chen M
    Chin Med J (Engl); 2002 May; 115(5):770-2. PubMed ID: 12133554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transdermal scopolamine on heart rate variability in normal subjects.
    Vybiral T; Bryg RJ; Maddens ME; Bhasin SS; Cronin S; Boden WE; Lehmann MH
    Am J Cardiol; 1990 Mar; 65(9):604-8. PubMed ID: 2309630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different impact of carvedilol and transdermal scopolamine on cardiovascular performance of mild-moderate chronic heart failure patients: evidence of useful effects of scopolamine on tolerance to work load.
    De Vecchis R; Pucciarelli G; Setaro A; Nocerino L
    Minerva Cardioangiol; 2000 Nov; 48(11):393-410. PubMed ID: 11214431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of double-dose transdermal scopolamine.
    Bar R; Gil A; Tal D
    Pharmacotherapy; 2009 Sep; 29(9):1082-8. PubMed ID: 19698013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-dose transdermal scopolamine on autonomic cardiovascular control in healthy young subjects.
    Vesalainen RK; Tahvanainen KU; Kaila TJ; Kantola IM; Kuusela TA; Eckberg DL
    Clin Physiol; 1997 Mar; 17(2):135-48. PubMed ID: 9156960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low doses of scopolamine increase cardiac vagal tone in the acute phase of myocardial infarction.
    Casadei B; Pipilis A; Sessa F; Conway J; Sleight P
    Circulation; 1993 Aug; 88(2):353-7. PubMed ID: 8339398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are the acute effects of transdermal estradiol in postmenopausal women with coronary disease related to changes of the autonomic tone?].
    Schuchert A; Liebau M; Behrens G; Mueck AO; Meinertz T
    Z Kardiol; 2002 Feb; 91(2):156-60. PubMed ID: 11963733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sympathetic regulation in rabbits with heart failure: experience using power spectral analysis of heart rate variability.
    Moguilevski V; Oliver J; McGrath BP
    Clin Exp Pharmacol Physiol; 1995; 22(6-7):475-7. PubMed ID: 8582108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectral analysis of heart rate variability as a quantitative measure of parasympatholytic effect--integrated pharmacokinetics and pharmacodynamics of three anticholinergic drugs.
    Scheinin H; Helminen A; Huhtala S; Grönroos P; Bosch JA; Kuusela T; Kanto J; Kaila T
    Ther Drug Monit; 1999 Apr; 21(2):141-51. PubMed ID: 10217331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of creatine phosphate in patients with congestive heart failure: a double-blind comparison trial versus placebo.
    Ferraro S; Codella C; Palumbo F; Desiderio A; Trimigliozzi P; Maddalena G; Chiariello M
    Clin Cardiol; 1996 Sep; 19(9):699-703. PubMed ID: 8874988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure.
    Bullinga JR; Alharethi R; Schram MS; Bristow MR; Gilbert EM
    J Card Fail; 2005 Dec; 11(9):693-9. PubMed ID: 16360965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. n-3PUFA and Holter-derived autonomic variables in patients with heart failure: data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca (GISSI-HF) Holter substudy.
    La Rovere MT; Staszewsky L; Barlera S; Maestri R; Mezzani A; Midi P; Marchioli R; Maggioni AP; Tognoni G; Tavazzi L; Latini R;
    Heart Rhythm; 2013 Feb; 10(2):226-32. PubMed ID: 23107655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.